An Open-Label Study Of Lamictal In Neurotic Excoriation
An Open-Label Study of Lamictal In Neurotic Excoriation
Sponsor: University of Minnesota
Listed as NCT00269594, this PHASE2 trial focuses on Neurotic Disorders and Obsessive-Compulsive Disorder and remains completed. Sponsored by University of Minnesota, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Jun 2018 — Nov 2019 [monthly]
Completed PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE2
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .